Please assess the completion status of the following clinical trial:

Trial Title: Nicotine Mouth Film for Craving Relief.

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* BMI within the range of 19-35 kg/m2;~* Current cigarette smokers who have smoked regularly daily for at least a year,~* Participants who smoke their first cigarette more than 30 minutes after waking up~Exclusion Criteria:~* Known or suspected intolerance or hypersensitivity to nicotine (or closely related compounds) or any of the stated ingredients in formulation.~* Any participant whose CO level rises during the sequestration period (i.e., the subject's two expired CO assessments immediately prior to the provoked craving paradigm are higher than the mean baseline CO assessment) and, in the opinion of the investigator, may have smoked during that time.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Nicotine Mouth Film (Type: EXPERIMENTAL): mint nicotine mouth film, buccal administration
- Nicotine Lozenge (Type: ACTIVE_COMPARATOR): nicotine lozenge, buccal administration

Based on this trial design, predict the completion outcome and termination type (if applicable).